Streetbeat News

Products Services

GNRC

Generac Holdings shares are experiencing an uptick in trading due to Hurricane Helene, as the company specializes in generators and power equipment.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 7:10 pm

RIVN

Rivian has teased a new product or service launch for October via a post on X, suggesting potential upcoming developments for the company.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:38 pm

GME

KOSS

GameStop has announced the preorder availability of Chromatic games and exclusive Koss headphones through a repost on social media. This collaboration could potentially boost sales for both GameStop and Koss Corporation.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:35 pm

AAPL

META

MSFT

Meta Platforms Inc (NASDAQ:META) received multiple analyst re-ratings following its Meta Connect conference, highlighting advancements in AI and VR. Analysts raised price targets, citing Meta's progress in hardware and AI, with potential for Apple-like valuation. Meta's stock is slightly down.

Portfolio Pulse from Anusuya Lahiri

September 26, 2024 | 6:19 pm

LUV

UAL

United Airlines (UAL) stock surged 9.13% to a new 52-week high, driven by positive sector sentiment following Southwest Airlines' (LUV) $2.5 billion stock buyback and optimistic revenue forecasts. Lower fuel costs and Southwest's ambitious growth targets also contributed to the rally.

Portfolio Pulse from Henry Khederian

September 26, 2024 | 6:14 pm

FSLR

Truist Securities analyst Jordan Levy initiated coverage on First Solar, Inc. (NASDAQ:FSLR) with a Buy rating and a $300 price target. Levy highlights First Solar's competitive edge due to its technology, R&D investments, and contracted backlog. The company is expected to benefit from the push to onshore U.S. manufacturing and has a strong long-term growth profile despite market volatility.

Portfolio Pulse from Nabaparna Bhattacharya

September 26, 2024 | 6:13 pm

CSD

FRNW

GEV

GE Vernova Inc. (NYSE:GEV) is expected to generate $2.5 billion in free cash flow by 2026, driven by energy transition trends. Truist Securities initiated coverage with a Buy rating and a $300 price target. The company is positioned for growth in the electrification segment and has been selected for a hydrogen project by the U.S. Department of Energy.

Portfolio Pulse from Lekha Gupta

September 26, 2024 | 6:08 pm

FULC

Fulcrum Therapeutics shares rose following Pfizer's decision to withdraw its sickle cell treatment, potentially benefiting Fulcrum's market position.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:03 pm

BMEA

The FDA has lifted the clinical hold on Biomea Fusion's BMF-219, allowing the continuation of Phase I/II trials for Type 1 and Type 2 diabetes. This development is significant for Biomea Fusion as it progresses in its clinical trials.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:01 pm

ENTA

Enanta Pharmaceuticals reported positive results from a Phase 2a study of its antiviral EDP-323 for RSV, showing significant reductions in viral load and symptoms. The drug, which has FDA Fast Track designation, demonstrated a favorable safety profile and pharmacokinetics. Enanta is also developing another RSV treatment, zelicapavir.

Portfolio Pulse from Vandana Singh

September 26, 2024 | 6:00 pm